Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hengfeng Sugar Group is a prominent Chinese biotechnology enterprise focused on the research, development, and large-scale production of functional sugar alcohols. The company is a major global supplier of health-oriented ingredients including xylitol, erythritol, maltitol, and L-arabinose, which are produced through biological fermentation and specialized chemical processes. Its products are widely utilized as low-glycemic sweeteners and pharmaceutical excipients in the food, beverage, and healthcare sectors. Headquartered in Yucheng, known as China's "Functional Sugar Capital," the company maintains rigorous quality standards to serve international markets. Hengfeng Sugar plays a critical role in the supply chain for metabolic health products and sugar-free alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengfeng Sugar.